These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tobramycin population pharmacokinetics in neonates. de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN. Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390 [Abstract] [Full Text] [Related]
10. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age. Sundaram A, Alshaikh B, Dersch-Mills D, Dobry J, Akierman AR, Yusuf K. Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209 [Abstract] [Full Text] [Related]
11. Validation of a dosage individualization table for extended-interval gentamicin in neonates. Dersch-Mills D, Akierman A, Alshaikh B, Yusuf K. Ann Pharmacother; 2012 Jun; 46(7-8):935-42. PubMed ID: 22739714 [Abstract] [Full Text] [Related]
12. Extended interval dosing of gentamicin in premature neonates ≤ 28-week gestation. Alshaikh B, Dersch-Mills D, Taylor R, Akierman AR, Yusuf K. Acta Paediatr; 2012 Nov; 101(11):1134-9. PubMed ID: 22897142 [Abstract] [Full Text] [Related]
14. Vancomycin population pharmacokinetics in neonates. de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN. Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244 [Abstract] [Full Text] [Related]
15. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. de Hoog M, Mouton JW, Schoemaker RC, Verduin CM, van den Anker JN. Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820 [Abstract] [Full Text] [Related]